1. Home
  2. VSME vs GNLX Comparison

VSME vs GNLX Comparison

Compare VSME & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • GNLX
  • Stock Information
  • Founded
  • VSME 2013
  • GNLX 2001
  • Country
  • VSME Hong Kong
  • GNLX United States
  • Employees
  • VSME 46
  • GNLX N/A
  • Industry
  • VSME
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSME
  • GNLX Health Care
  • Exchange
  • VSME Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • VSME 103.9M
  • GNLX 128.0M
  • IPO Year
  • VSME 2023
  • GNLX 2023
  • Fundamental
  • Price
  • VSME $2.28
  • GNLX $4.70
  • Analyst Decision
  • VSME
  • GNLX Strong Buy
  • Analyst Count
  • VSME 0
  • GNLX 4
  • Target Price
  • VSME N/A
  • GNLX $17.75
  • AVG Volume (30 Days)
  • VSME 2.4M
  • GNLX 133.8K
  • Earning Date
  • VSME 04-14-2025
  • GNLX 11-13-2025
  • Dividend Yield
  • VSME N/A
  • GNLX N/A
  • EPS Growth
  • VSME N/A
  • GNLX N/A
  • EPS
  • VSME N/A
  • GNLX N/A
  • Revenue
  • VSME $8,248,108.00
  • GNLX N/A
  • Revenue This Year
  • VSME N/A
  • GNLX N/A
  • Revenue Next Year
  • VSME N/A
  • GNLX N/A
  • P/E Ratio
  • VSME N/A
  • GNLX N/A
  • Revenue Growth
  • VSME 3.22
  • GNLX N/A
  • 52 Week Low
  • VSME $0.51
  • GNLX $1.99
  • 52 Week High
  • VSME $3.69
  • GNLX $5.89
  • Technical
  • Relative Strength Index (RSI)
  • VSME 43.87
  • GNLX 70.91
  • Support Level
  • VSME $2.11
  • GNLX $4.17
  • Resistance Level
  • VSME $2.68
  • GNLX $4.45
  • Average True Range (ATR)
  • VSME 0.32
  • GNLX 0.28
  • MACD
  • VSME -0.11
  • GNLX 0.03
  • Stochastic Oscillator
  • VSME 17.08
  • GNLX 87.00

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: